CLINICAL_TRIALS
trial_result
· 2010-03-12
Clinical Trial Update: A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers [Phase 1]
Summary
Pfizer completed a Phase 1 radiolabeled mass-balance study of [14C]PF-00299804 in healthy male volunteers, assessing pharmacokinetics and excretion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED